IMM
Click for more information
1.72% 28.5¢ immutep limited

competition

  1. cerbera
    3,057 Posts.
    lightbulb Created with Sketch. 24
    clock Created with Sketch.
    07/10/09
    13:31
    Post #: 5743906
    http://clinicaltrials.gov/ct2/show/NCT00113607

    Phase iii trials

    Study Start Date: April 2005
    Estimated Study Completion Date: May 2011
    PRR Price at posting: 26.0¢ Sentiment: Sell Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
28.5¢ 		Change
-0.005(1.72%) 		Mkt cap ! $413.9M
Open High Low Value Volume
29.0¢ 29.5¢ 28.0¢ $1.441M 5.001M

Buyers (Bids)

No. Vol. Price($)
6 102393 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 14707 1
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.